Pharmaceuticals

Dukoral Market 2026–2030: Forecast, Innovation, and Competitive Trends

March 5, 2026March 5, 2026 by Marketing Posting

Uncover key drivers, emerging technologies, and competitive movements shaping the dukoral market from 2026–2035 with trusted insights from The Business Research Company

What is the estimated market size of the Dukoral Market by the end of 2030?

Historically, expansion was influenced by factors such as cholera outbreaks in endemic regions, increasing international travel flows, government-issued vaccination advisories, the enduring prevalence of waterborne diseases, and the growing establishment of travel health clinics.

The projected growth throughout the forecast period stems from several factors: an uptick in global travel activities, the climate change-induced spread of cholera, increased spending on preventive healthcare, advancements in oral vaccine formulations, and a stronger emphasis on traveler health safety.

Prominent trends expected during the forecast period encompass the wider adoption of oral vaccines, an expansion in travel health immunization efforts, a growing focus on preventing enteric diseases, a preference for non-injectable vaccines, and heightened awareness regarding the risks of cholera and ETEC.

Access Your Free Sample Report for In-Depth Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=20040&type=smp

What Drivers Are Shaping Future Opportunities In The Dukoral Market?

The escalating occurrence of cholera cases is anticipated to propel the expansion of the dukoral market. Cholera, an acute diarrheal illness caused by consuming food or water tainted with Vibrio cholerae, leads to severe dehydration and, in extreme cases, death. The surge in cholera is primarily driven by inadequate sanitation, contaminated water, and climate change, which together create ideal conditions for outbreaks. Dukoral, an oral cholera vaccine, aids in reducing cholera instances by stimulating immunity against the Vibrio cholerae bacteria and its toxin, thereby lowering the risk of infection. For instance, in September 2024, the World Health Organization (WHO), a Switzerland-based intergovernmental organization, stated that in 2023, cholera cases climbed by 13%, alongside a significant 71% surge in fatalities compared to 2022, resulting in over 4,000 deaths from a preventable and easily treatable disease. Hence, the increasing incidence of cholera cases is projected to fuel the growth of the dukoral market.

Which Segment Groups Are Influencing The Dukoral Market?

The dukoral market covered in this report is segmented –

1) By Indication: Cholera, Traveler’s Diarrhea

2) By Distribution Channel: Pharmacies, Travel Clinics, Healthcare Providers

3) By End Use: Hospitals, Clinics, Ambulatory Care, Home Care

Which Innovation Trends Are Advancing Developments Within The Dukoral Market?

Leading companies in the dukoral market are concentrating on developing novel vaccine formulations, specifically low-cost oral cholera vaccines, to boost their effectiveness and ease of use. These affordable vaccines are crafted to prevent cholera, providing simpler administration and better accessibility, particularly in areas with limited resources. Essentially, low-cost oral cholera vaccines are cost-effective, orally delivered vaccines intended to safeguard against cholera, especially in low-resource and outbreak-prone areas. As an example, in April 2023, the International Vaccine Institute (IVI), a non-profit international organization based in South Korea, collaborated with the University of Gothenburg, an institution situated in Sweden, to create DuoChol, a low-cost oral cholera vaccine (OCV). This partnership endeavors to accelerate the advancement of DuoChol, characterized by its dry formulation of inactivated bacterial whole cells and cholera toxin B subunit presented in a capsule. While sharing a comparable composition with DUKORAL, it provides enhanced thermostability, improved stability at elevated temperatures, and a decrease in weight and volume. The Phase I clinical trial for this vaccine is slated to be conducted in Sweden, with funding provided by the Wellcome Trust and the Swedish government.

Who Are The Top-Performing Companies In The Dukoral Market In Recent Years?

Major companies operating in the dukoral market are Valneva SE

Access The Complete Report For Deeper Market Insights:

https://www.thebusinessresearchcompany.com/report/dukoral-global-market-report

Which Region Currently Holds The Largest Share Of The Dukoral Market?

Asia-Pacific was the largest region in the dukoral market in 2025. The regions covered in the dukoral market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request Your Customized Dukoral Market Research Report for Competitive Advantage:

https://www.thebusinessresearchcompany.com/customise?id=20040&type=smp

Browse Through More Reports Similar to the Global Dukoral Market 2026, By The Business Research Company

Direct Selling Market Report 2026

https://www.thebusinessresearchcompany.com/report/direct-selling-global-market-report

Data Lake Market Report 2026

https://www.thebusinessresearchcompany.com/report/data-lake-global-market-report

Inductor Market Market Report 2026

https://www.thebusinessresearchcompany.com/report/inductor-market-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795